AC

Anshul Chhabra

Active Director Director DIN 08070427
DIN 08070427 First appointment Apr 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2018
Shareholding value •••• Premium profile

About Anshul Chhabra

Data last updated:

Anshul Chhabra is a Director at Dexbio Pharma Private Limited (since 2018). The company operates in Pharma. Dexbio Pharma Private Limited reported revenue of ₹21.52 Cr (FY 2025).

DIN 08070427
Primary Designation Director
Industry Pharma
First Appointment 23 Apr 2018
Oldest Company Age 20 yrs
Largest company Dexbio Pharma Private Limited · ₹21.52 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dexbio Pharma Private Limited U24232UR2006PTC011840
Director23 Apr 20182006₹21.52 Cr (FY 2025)Active

Board colleagues of Anshul Chhabra

Directorship timeline

Open interactive timeline →
Dexbio Pharma Private Limited
Premium access

Shareholding and investment profile for Anshul Chhabra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anshul Chhabra

Anshul Chhabra currently holds 1 directorship: Dexbio Pharma Private Limited (Director, since 23 Apr 2018, revenue ₹21.52 Cr (FY 2025)).

Anshul Chhabra was first appointed on 23 Apr 2018 as Director at Dexbio Pharma Private Limited.

The current boards of Anshul Chhabra's companies include Rajeev Kumar Chhabra (Dexbio Pharma Private Limited), Venkata Rangaiah Kothuri (Dexbio Pharma Private Limited), Venkata Subbarao (Dexbio Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available